| Id |
Subject |
Object |
Predicate |
Lexical cue |
ForCovid19 |
tao:has_database_id |
| 3 |
0-9 |
Chemical |
denotes |
Sarilumab |
inhibitor|drug |
MESH:C000592401 |
| T173 |
17-33 |
Therapy |
denotes |
standard of care |
|
MESH:D059039 |
| T168 |
42-47 |
Condition |
denotes |
early |
|
|
| 4 |
61-79 |
Disease |
denotes |
COVID-19 pneumonia |
|
MESH:D000086382 |
| T4 |
83-95 |
Severity |
denotes |
hospitalized |
|
|
| 5 |
96-104 |
Species |
denotes |
patients |
|
Tax:9606 |
| T230 |
161-188 |
TrialDesign |
denotes |
randomised controlled trial |
|
|
| R221 |
4 |
T173 |
for |
COVID-19 pneumonia,standard of care |
| R222 |
4 |
3 |
for |
COVID-19 pneumonia,Sarilumab |
| R223 |
T168 |
T173 |
of_a |
early,standard of care |
| R224 |
T168 |
3 |
of_a |
early,Sarilumab |
| R62 |
T4 |
5 |
of_a |
hospitalized,patients |
| R88 |
4 |
5 |
has_a |
COVID-19 pneumonia,patients |
